DANUBE AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101 CHF | -4.45% |
|
-5.39% | +9.73% |
| Jun. 03 | Global markets live: GSK, Walt Disney, Blackstone, Boeing, Microsoft... |  |
| Jun. 03 | Dsm-firmenich to De-prioritize Certain Business Activities Under New Strategy | MT |
| Sales 2024 * | 12.62B 13.75B 12.3B | Sales 2025 * | 13.27B 14.46B 12.94B | Capitalization | 26.78B 29.2B 26.12B |
|---|---|---|---|---|---|
| Net income 2024 * | 453M 494M 442M | Net income 2025 * | 810M 883M 790M | EV / Sales 2024 * | 2.36 x |
| Net Debt 2024 * | 2.95B 3.22B 2.88B | Net Debt 2025 * | 2.69B 2.93B 2.62B | EV / Sales 2025 * | 2.22 x |
| P/E ratio 2024 * |
58
x | P/E ratio 2025 * |
33.2
x | Employees | 28,685 |
| Yield 2024 * |
2.49% | Yield 2025 * |
2.45% | Free-Float | 25.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danube AG
More press releases
More news
| 1 day | -4.45% | ||
| 1 week | -5.39% | ||
| Current month | -4.45% | ||
| 1 month | -3.49% | ||
| 3 months | +0.87% | ||
| 6 months | +17.36% | ||
| Current year | +9.73% |
1 week
100.35
106.75
1 month
100.35111.10
Current year
85.86111.10
1 year
75.45111.10
3 years
75.45122.06
5 years
75.45122.06
10 years
75.45122.06
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
| Director/Board Member | 62 | 23-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.82% | 12 M€ | +15.09% | - | |
| 0.51% | 10 M€ | +6.14% | - | |
| 0.37% | 88 M€ | +10.37% | - | |
| 0.22% | 4 M€ | -.--% | - | |
| 0.20% | 6 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-03 | 101 | -4.45% | 824,578 |
| 24-05-31 | 105.6 | +1.10% | 840,472 |
| 24-05-30 | 104.5 | -0.76% | 393,338 |
| 24-05-29 | 105.3 | -1.17% | 390,824 |
| 24-05-28 | 106.6 | -0.14% | 296,376 |
End-of-day quote Euronext Amsterdam, June 02, 2024
More quotes
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
2024-07-30
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
101
EUR
Average target price
121.9
EUR
Spread / Average Target
+20.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.73% | 29.15B | |
| +2.53% | 245B | |
| +26.51% | 177B | |
| -3.46% | 132B | |
| +62.83% | 98.33B | |
| -8.43% | 71.58B | |
| -8.74% | 55.2B | |
| +38.47% | 36.86B | |
| -39.36% | 30.49B | |
| +73.70% | 29.93B |
- Stock Market
- Equities
- DSFIR Stock
